
Mazdutide
A GLP-1 and glucagon receptor dual agonist studied primarily in metabolic research programs.
Read the Mazdutide research guide→In stock
✓ 100% purity-match & safe-arrival guarantee
✓ Orders placed before 2:00 PM CT on a business day ship the same day.
✓ Free shipping over $200. One discount per order.
- Best value!Make this a kitMazdutide + 3 mL BAC water + 10 syringes + 10alcohol pads — pads free, water & syringes 25% offStarting at$110.11$118.14
- Bacteriostatic Water0.9% benzyl alcohol water for reconstitution, sold as a single vial.$13.14
- Insulin Syringes31G 0.5 mL sterile syringes, sold in packs of 10, 100, or 300.$7
- Alcohol Prep Pads70% isopropyl alcohol pads, sold in packs of 10 or 200.$3
Molecular specification
- Molecular formula
- C202H318N48O61
- Molecular weight
- 4404.9 g/mol
- CAS number
- 2609174-40-3
- Amino acids
- 29
- Appearance
- White lyophilized powder
- Purity (HPLC)
- 98.9%
- Elimination half-life
- ≈ 7 days (reported 7–45 d across doses)
Mechanism & published research
Dual GLP-1/glucagon receptor agonism, related in class to other glucagon-containing agonists.
Characterized in early-phase metabolic trials.
Honest note on evidence: Human literature is limited; the profile above reflects early-phase and mechanistic data only.
Descriptions summarize existing published research and are not claims about outcomes from use. Every citation states its study type and population.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| Survodutide | Class | Both are GLP-1/glucagon dual agonists with differing sequences. |
Reconstitution
Concentration math only: add bacteriostatic water to the vial and the resulting concentration is shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 5 mg | 1 mL | 5 mg/mL |
| 10 mg | 1 mL | 10 mg/mL |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Lyophilized (unopened) | -20°C | 24 months |
| Reconstituted | 2–8°C | up to 4 weeks |
Reviews
Reviews are collected post-delivery and screened to exclude any human-use or dosing-outcome claims before publication. They speak to product quality, shipping, and COA accuracy.
“Lot verified externally and matched the hub. Solid transparency for a less common compound.”
Product FAQ
How does it differ from survodutide?+
Both target GLP-1 and glucagon receptors; sequences and pharmacokinetics differ. See the comparison table.
Related compounds

Retatrutide
Triple GLP-1 / GIP / glucagon receptor agonist under study.

Tirzepatide
Dual GIP / GLP-1 receptor agonist, extensively studied.

Semaglutide
GLP-1 receptor agonist with a deep clinical literature.

Cagrilintide
Long-acting amylin analog studied with incretins.